Evaluation Of The Efficacy Of The Combination Of GLIZIGEN® Oral Solution 1/Day And Vaginal Gel 1/Night For 2 Months In Patients With Cervical Intraepithelial Neoplasia Grade 1 (LSIL/CIN-1) Caused By High-Risk Human Papillomavirus (HPV-AR)
Conditions
- Papilloma Viral Infection
- CIN1
- LSIL, Low Grade Squamous Intraepithelial Lesion
Interventions
- DIETARY_SUPPLEMENT: Glizigen
- OTHER: Placebo
Sponsor
Catalysis SL
Collaborators